Dissonance in the face of Alzheimer's disease breakthroughs: clinician and lay stakeholder acceptance, concerns and willingness to pay for emerging disease-modifying therapiesIrina Kinchin, Iracema Leroi, Rachel Dinh et al.|The British Journal of Psychiatry|2024Cited by 7